Suppr超能文献

关于药品安全问题沟通的意外后果:文献综述的批判性回顾。

Unintended Effects of Communicating About Drug Safety Issues: A Critical Review of the Literature.

机构信息

Center for Communication Science, RTI International, 3040 E. Cornwallis Road, Research Triangle Park, PO Box 12194, NC, USA.

出版信息

Drug Saf. 2019 Oct;42(10):1125-1134. doi: 10.1007/s40264-019-00840-3.

Abstract

Communications about the safety and effectiveness of human drugs can influence patients' and prescribers' perceptions and behaviors, which in turn can affect the public's health more broadly. We conducted a critical review of the literature on the unintended effects from communicating information to the public about safety issues with prescription and over-the-counter drugs. We searched PubMed for peer-reviewed studies published from 1990 to 2017 where study authors reported probable unintended effects of communicating drug safety. The types of communications included in these studies were news reports, direct-to-consumer advertisements, and those released by government agencies. Among the 26 studies identified, the most commonly reported unintended effects were decreased drug use or discontinuation. Other unintended effects included spillover to populations not targeted by the communications (e.g., discontinuation of antidepressants among adults following communications concerning use among youth), shifts in clinical diagnoses (e.g., fewer diagnoses of depression), increased use of alternative therapies, and other undesirable behaviors (e.g., possible increased suicide attempts because antidepressants were discontinued). Limitations to the literature include the inability to establish causation or to isolate the effects of multiple communication sources and messages. Further, because the intended effect of many communications was not known, our study was limited by challenges in defining some effects as unintended. Most studies used health insurer claims data to identify unintended effects of communications, which provide an incomplete picture; few used self-reported or other methodologies that could help illuminate the reasons underlying the effects observed in the claims data. Best practices for communicating about the potential benefits and harms of drugs in a manner that minimizes negative unintended effects are needed to protect and improve public health.

摘要

关于人类药物安全性和有效性的信息交流可以影响患者和处方者的认知和行为,进而更广泛地影响公众健康。我们对关于向公众传达处方和非处方药物安全问题信息所产生的意外影响的文献进行了批判性回顾。我们在 PubMed 上搜索了 1990 年至 2017 年期间发表的同行评议研究,研究作者报告了与药物安全性沟通相关的可能的意外影响。这些研究中包含的沟通类型包括新闻报道、直接面向消费者的广告以及政府机构发布的信息。在确定的 26 项研究中,报告最多的意外影响是减少药物使用或停药。其他意外影响包括溢出到沟通目标人群之外的人群(例如,在青年人群中使用沟通之后,成年人停止使用抗抑郁药)、临床诊断的转变(例如,抑郁症的诊断减少)、替代疗法的增加以及其他不良行为(例如,因为抗抑郁药停药,可能增加自杀企图)。文献的局限性包括无法确定因果关系或隔离多个沟通来源和信息的影响。此外,由于许多沟通的预期效果未知,因此我们的研究受到限制,因为难以将一些效果定义为意外效果。大多数研究使用健康保险公司理赔数据来确定沟通的意外影响,这些数据提供了不完整的信息;很少有研究使用自我报告或其他方法学,这些方法可以帮助阐明理赔数据中观察到的效果的原因。需要制定以最小化负面意外影响的方式交流药物潜在益处和危害的最佳实践,以保护和改善公众健康。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验